References
- Gandini S, Ferrucci PF, Botteri E, et al. Prognostic significance of hematological profiles in melanoma patients. Int J Cancer. 2016;139:1618–1625.
- Margolis KL, Rodabough RJ, Thomson CA, et al. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med. 2007;167:1837–1844.
- Montagnana M, Danese E. Red cell distribution width and cancer. Ann Transl Med. 2016;4:399.
- Song CS, Park DI, Yoon MY, et al. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci. 2012;57:1033–1038.
- Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163–168.
- Chen S, Zhang L, Yan G, et al. Neutrophil-to-lymphocyte ratio is a potential prognostic biomarker in patients with ovarian cancer: a meta-analysis. Biomed Res Int. 2017;2017:7943467.
- Ethier JL, Desautels D, Templeton A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19:2.
- Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.
- Feng JR, Qiu X, Wang F, et al. Diagnostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Crohn’s disease. Gastroenterol Res Pract. 2017;2017:3526460
- Nishida Y, Hosomi S, Yamagami H, et al. Neutrophil-to-lymphocyte ratio for predicting loss of response to infliximab in ulcerative colitis. PLoS One. 2017;12:e0169845.
- Benites-Zapata VA, Hernandez AV, Nagarajan V, et al. Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am J Cardiol. 2015;115:57–61.
- Quiros-Roldan E, Raffetti E, Donato F, et al. Neutrophil to lymphocyte ratio and cardiovascular disease incidence in HIV-infected patients: a population-based cohort study. PLoS One. 2016;11:e0154900.
- Zhang Z. Propensity score method: a non-parametric technique to reduce model dependence. Ann Transl Med. 2017;5:7.
- Sachs MC. plotROC: a tool for plotting ROC curves. J Stat Softw. 2017;79:2.
- Baicus C, Caraiola S, Rimbas M, et al. Utility of routine hematological and inflammation parameters for the diagnosis of cancer in involuntary weight loss. J Invest Med. 2011;59:951–955.
- Ellingsen TS, Lappegard J, Skjelbakken T, et al. Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study. Haematologica. 2015;100:e387–e389.
- Lee H, Kong SY, Sohn JY, et al. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. Biomed Res Int. 2014;2014:145619.
- Qin Y, Wang P, Huang Z, et al. The value of red cell distribution width in patients with ovarian cancer. Medicine. 2017;96:e6752.
- Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454:436–444.
- Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023.
- Faria SS, Fernandes PC, Jr., Silva MJ, et al. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience. 2016;10:702.
- Gunay E, Sarinc US, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37:374–380.
- Assinger A. Platelets and infection – an emerging role of platelets in viral infection. Front Immunol. 2014;5:649.
- Koupenova M, Vitseva O, MacKay CR, et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood. 2014;124:791–802.